Ordaos Bio

Ordaos is creating the next generation of more effective cancer therapeutics 30x faster than ever before with its generative mini-protein design engine.

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location New York, NY, USA
  • Currency USD
  • Founded December 2019
  • Employees 21
  • Incorporation Type C-corp
  • Website ordaos.bio

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free